What should be the HPV vaccine strategy for India?
Dr Rengaswamy Sankaranarayanan - WHO-IARC, Lyon, France
What should be the HPV vaccine strategy for India? ( Dr Rengaswamy Sankaranarayanan - WHO-IARC, Lyon, France )
7 Nov 2019
SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer...
Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA
SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer patients during the dose escalation phase ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )
4 Oct 2019
HPV: The global threat of vaccination hesitancy
Dr Carlos Castro - Liga Colombiana Contra el Cáncer, Colombia
HPV: The global threat of vaccination hesitancy ( Dr Carlos Castro - Liga Colombiana Contra el Cáncer, Colombia )
7 Aug 2019
Cancer control in Africa - Special Issue
Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es S...
Cancer control in Africa - Special Issue ( Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania )
25 Jul 2019
Role of interventional oncology for immunology treatment
Prof Thierry De Baere - Institut Gustave Roussy, Paris, France
Role of interventional oncology for immunology treatment ( Prof Thierry De Baere - Institut Gustave Roussy, Paris, France )
8 May 2019
Highlights from IGILUC 2019
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
The WIN symposium 2019
Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019
An overview of the WIN consortium
Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncolo...
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019
Making oncology global with the WIN consortium
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019
The translational element of the WIN consortium
Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019
How the WIN consortium achieves its goals
Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA
How the WIN consortium achieves its goals ( Prof Apostolia-Maria Tsimberidou - MD Anderson Cancer Centre, Houston, USA )
25 Apr 2019
Cancer preventive vaccine used in mouse model of Lynch syndrome
Prof Steven Lipkin - Weill Cornell Medical College, New York, USA
Cancer preventive vaccine used in mouse model of Lynch syndrome ( Prof Steven Lipkin - Weill Cornell Medical College, New York, USA )
15 Apr 2019